Erratum to: Odanacatib Restores Trabecular Bone of Skeletally Mature Female Rabbits With Osteopenia but Induces Brittleness of Cortical Bone: A Comparative Study of the Investigational Drug With PTH, Estrogen, and Alendronate: ODANACATIB ALTERS DUCTILITY OF FEMUR (Journal of Bone and Mineral Research, (2016), 31, 3, (615-629), 10.1002/jbmr.2719);Odanacatib Restores Trabecular Bone of Skeletally Mature Female Rabbits with Osteopenia but Induces Brittleness of Cortical Bone: A Comparative Study of the Investigational Drug with PTH, Estrogen, and Alendronate

Journal of Bone and Mineral Research

Volumn 31, Issue 3, 2016, Pages 615-629

  Khan, Mohd Parvez ^a   Singh, Atul Kumar ^b   Singh, Abhishek Kumar ^a   Shrivastava, Pragya ^b   Tiwari, Mahesh Chandra ^a   Nagar, Geet Kumar ^a   Bora, Himangshu Kousik ^a   Parameswaran, Venkitanarayanan ^c   Sanyal, Sabyasachi ^a   Bellare, Jayesh R ^b   Chattopadhyay, Naibedya ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b INDIAN INSTITUTE OF TECHNOLOGY BOMBAY   (India)

^c INDIAN INSTITUTE OF TECHNOLOGY KANPUR   (India)

Author keywords

CATHEPSIN K; CRYSTALLINITY; ODANACATIB; STROMAL CELLS; TISSUE MINERALIZATION

Indexed keywords

17B ESTRADIOL; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; AGENTS ACTING ON THE PERIPHERAL NERVOUS AND NEUROMUSCULAR SYSTEMS; ALENDRONIC ACID; CALCIUM; CATHEPSIN D; CATHEPSIN K; ESTROGEN; ODANACATIB; PARATHYROID HORMONE; PHOSPHORUS; PROCOLLAGEN; PROCOLLAGEN TYPE 1; UNCLASSIFIED DRUG; BIPHENYL DERIVATIVE; NEW DRUG;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; BONE DENSITY; BONE FORMATION RATE; BONE LEVEL; BONE MARROW STROMA CELL; BONE MASS; BONE REGENERATION; BONE REMODELING; BONE STRUCTURE; CALCIUM BONE LEVEL; CELL ACTIVITY; CELL COUNT; CELL SURFACE; COMPARATIVE STUDY; COMPRESSIVE STRENGTH; CONCENTRATION RESPONSE; CONNECTIVITY DENSITY; CONTROLLED STUDY; CORTICAL BONE; CORTICAL THICKNESS (BONE); CRYSTAL STRUCTURE; DIAPHYSIS; DRUG EFFICACY; EXPERIMENTAL RABBIT; FEMALE; FEMUR METAPHYSIS; IN VITRO STUDY; IN VIVO STUDY; LUMBAR VERTEBRA; MINERAL APPOSITION RATE; MINERALIZING SURFACE PER BONE SURFACE; MORPHOMETRICS; MUSCULOSKELETAL SYSTEM PARAMETERS; NONHUMAN; OSTEOBLAST; OSTEOCLAST ACTIVITY; OSTEOPENIA; OSTEOPOROSIS; PERIOSTEUM; PHOSPHORUS BONE LEVEL; PROTEIN EXPRESSION; RIGIDITY; TRABECULAR BONE; TREATMENT DURATION; UTERUS WEIGHT; WEIGHT GAIN; ANIMAL; BIOMECHANICS; BONE DISEASES, METABOLIC; BONE MINERALIZATION; CRYSTALLIZATION; DRUG EFFECTS; FEMUR; OSTEOCLAST; PATHOLOGY; PATHOPHYSIOLOGY; RABBIT;

ALENDRONATE; ANIMALS; BIOMECHANICAL PHENOMENA; BIPHENYL COMPOUNDS; BONE DENSITY; BONE DISEASES, METABOLIC; CALCIFICATION, PHYSIOLOGIC; CANCELLOUS BONE; CORTICAL BONE; CRYSTALLIZATION; DIAPHYSES; DRUGS, INVESTIGATIONAL; ESTROGENS; FEMALE; FEMUR; LUMBAR VERTEBRAE; OSTEOBLASTS; OSTEOCLASTS; OSTEOPOROSIS; PARATHYROID HORMONE; RABBITS;

EID: 84949669547     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.3536     Document Type: Erratum

References (58)

1. Drake FH, Dodds RA, James IE, et al., Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts. J Biol Chem. 1996 May; 271 (21): 12511-6.
2. Blair HC, Kahn AJ, Crouch EC, Jeffrey JJ, Teitelbaum SL., Isolated osteoclasts resorb the organic and inorganic components of bone. J Cell Biol. 1986 Apr; 102 (4): 1164-72.
3. Gelb BD, Shi GP, Chapman HA, Desnick RJ., Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science. 1996 Aug; 273 (5279): 1236-8.
4. Gowen M, Lazner F, Dodds et al. Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization. J Bone Miner Res. 1999 Oct; 14 (10): 1654-63.
5. Kiviranta R, Morko J, Uusitalo H, Aro HT, Vuorio E, Rantakokko J., Accelerated turnover of metaphyseal trabecular bone in mice overexpressing cathepsin K. J Bone Miner Res. 2001 Aug;16(8): 1444-52.
6. Jensen PR, Andersen TL, Pennypacker BL, Duong LT, Delaissé J-M,. The bone resorption inhibitors odanacatib and alendronate affect post-osteoclastic events differently in ovariectomized rabbits. Calcif Tissue Int. 2014 Feb;94(2): 212-22.
7. Pennypacker BL, Duong LT, Cusick TE, et al., Cathepsin K inhibitors prevent bone loss in estrogen-deficient rabbits. J Bone Miner Res. 2011 Mar;26(2): 252-62.
8. Cusick T, Chen CM, Pennypacker BL, et al., Odanacatib treatment increases hip bone mass and cortical thickness by preserving endocortical bone formation and stimulating periosteal bone formation in the ovariectomized adult rhesus monkey. J Bone Miner Res. 2012 Mar;27(3): 524-37.
9. Hirano T, Burr DB, Turner CH, Sato M, Cain RL, Hock JM., Anabolic effects of human biosynthetic parathyroid hormone fragment (1-34), LY333334, on remodeling and mechanical properties of cortical bone in rabbits. J Bone Miner Res. 1999 Apr; 14 (4): 536-45.
10. Bone HG, McClung MR, Roux C, et al., Odanacatib, a cathepsin-K inhibitor for osteoporosis: a two-year study in postmenopausal women with low bone density. J Bone Miner Res. 2010 May;25(5): 937-47.
11. Langdahl B, Binkley N, Bone H, et al., Odanacatib in the treatment of postmenopausal women with low bone mineral density: five years of continued therapy in a phase 2 study. J Bone Miner Res. 2012 Nov;27(11): 2251-8.
12. Pennypacker BL, Oballa RM, Levesque S, Kimmel DB, Duong LT., Cathepsin K inhibitors increase distal femoral bone mineral density in rapidly growing rabbits. BMC Musculoskelet Disord. 2013 Jan; 14: 344.
13. Pennypacker B, Shea M, Liu Q, et al., Bone density, strength, and formation in adult cathepsin K (-/-) mice. Bone. 2009 Mar; 44 (2): 199-207.
14. Mandelin J, Hukkanen M, Li T-F, et al., Human osteoblasts produce cathepsin K. Bone. 2006 Jun; 38 (6): 769-77.
15. Stoch SA, Wagner JA., Cathepsin K inhibitors: a novel target for osteoporosis therapy. Clin Pharmacol Ther. 2008 Jan; 83 (1): 172-6.
16. Gilsanz V, Roe TF, Gibbens DT, et al., Effect of sex steroids on peak bone density of growing rabbits. Am J Physiol. 1988 Oct;255(4 Pt 1): E416-21.
17. Coxon FP, Helfrich MH, Van't Hof R, et al., Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298. J Bone Miner Res. 2000 Aug; 15 (8): 1467-76.
18. Bandyopadhyay S, Lion J-M, Mentaverri R, et al., Attenuation of osteoclastogenesis and osteoclast function by apigenin. Biochem Pharmacol. 2006 Jul; 72 (2): 184-97.
19. Gauthier JY, Chauret N, Cromlish W, et al., The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K. Bioorg Med Chem Lett. 2008 Mar; 18 (3): 923-8.
20. Fisher JE, Rogers MJ, Halasy JM, et al., Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro. Proc Natl Acad Sci USA. 1999 Jan; 96 (1): 133-8.
21. Kameda T, Mano H, Yuasa T, et al., Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts. J Exp Med. 1997 Aug; 186 (4): 489-95.
22. Mentaverri R, Yano S, Chattopadhyay N, et al., The calcium sensing receptor is directly involved in both osteoclast differentiation and apoptosis. FASEB J. 2006 Dec; 20 (14): 2562-4.
23. Khan MP, Mishra JS, Sharan K, et al., A novel flavonoid C-glucoside from Ulmus wallichiana preserves bone mineral density, microarchitecture and biomechanical properties in the presence of glucocorticoid by promoting osteoblast survival: a comparative study with human parathyroid hormone. Phytomedicine. 2013 Nov 15; 20 (14): 1256-66.
24. Ngueguim FT, Khan MP, Donfack JH, et al., Evaluation of Cameroonian plants towards experimental bone regeneration. J Ethnopharmacol. 2012 May 7;141(1): 331-7.
25. Vichai V, Kirtikara K., Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc. 2006 Jan; 1 (3): 1112-6.
26. Singh AK, Joharapurkar AA, Khan MP, et al., Orally active osteoanabolic agent GTDF binds to adiponectin receptors, with a preference for AdipoR1, induces adiponectin-associated signaling, and improves metabolic health in a rodent model of diabetes. Diabetes. 2014 Oct; 63 (10): 3530-44.
27. Khan MP, Singh AK, Joharapurkar AA, et al., Pathophysiological mechanism of bone loss in type 2 diabetes involves inverse regulation of osteoblast function by PPARγ coactivator-1α and skeletal muscle atrogenes: adiponectin receptor 1 as a potential target for reversing diabetes-induced osteopenia. Diabetes. 2015 Jul; 64 (7): 2609-23.
28. Marchand C, Chen H, Buschmann MD, Hoemann CD., Standardized three-dimensional volumes of interest with adapted surfaces for more precise subchondral bone analyses by micro-computed tomography. Tissue Eng Part C Methods. 2011 Apr;17(4): 475-84.
29. Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Müller R., Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res. 2010 Jul; 25 (7): 1468-86.
30. Srivastava K, Khan K, Tyagi AM, et al., Greater skeletal gains in ovary intact rats at maturity are achieved by supplementing a standardized extract of butea monosperma stem bark that confers better bone conserving effect following ovariectomy and concurrent treatment withdrawal. Evid Based Complement Alternat Med. 2013 Jan;2013: 519387.
31. Tyagi AM, Mansoori MN, Srivastava K, et al., Enhanced immunoprotective effects by anti-IL-17 antibody translates to improved skeletal parameters under estrogen deficiency compared with anti-RANKL and anti-TNF-α antibodies. J Bone Miner Res. 2014 Sep; 29 (9): 1981-92.
32. Albers J, Keller J, Baranowsky A, et al., Canonical Wnt signaling inhibits osteoclastogenesis independent of osteoprotegerin. J Cell Biol. 2013 Mar; 200 (4): 537-49.
33. Martin RB, Gibson VA, Stover SM, Gibeling JC, Griffin LV., Residual strength of equine bone is not reduced by intense fatigue loading: implications for stress fracture. J Biomech. 1997 Mar; 30 (2): 109-14.
34. Jepsen KJ, Pennington DE, Lee YL, Warman M, Nadeau J., Bone brittleness varies with genetic background in A/J and C57BL/6J inbred mice. J Bone Miner Res. 2001 Oct; 16 (10): 1854-62.
35. Dempster DW, Compston JE, Drezner MK, et al., Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 2013 Jan; 28 (1): 2-17.
36. Khan K, Sharan K, Swarnkar G, et al., Positive skeletal effects of cladrin, a naturally occurring dimethoxydaidzein, in osteopenic rats that were maintained after treatment discontinuation. Osteoporos Int. 2013 Apr; 24 (4): 1455-70.
37. Cassella JP, Garrington N, Stamp TC, Ali SY., An electron probe X-ray microanalytical study of bone mineral in osteogenesis imperfecta. Calcif Tissue Int. 1995 Mar; 56 (2): 118-22.
38. Kourkoumelis N, Balatsoukas I, Tzaphlidou M., Ca/P concentration ratio at different sites of normal and osteoporotic rabbit bones evaluated by Auger and energy dispersive X-ray spectroscopy. J Biol Phys. 2012 Mar; 38 (2): 279-91.
39. Jaiswal AK, Chhabra H, Soni VP, Bellare JR., Enhanced mechanical strength and biocompatibility of electrospun polycaprolactone-gelatin scaffold with surface deposited nano-hydroxyapatite. Mater Sci Eng C Mater Biol Appl. 2013 May; 33 (4): 2376-85.
40. Roschger P, Fratzl P, Eschberger J, Klaushofer K., Validation of quantitative backscattered electron imaging for the measurement of mineral density distribution in human bone biopsies. Bone. 1998 Oct; 23 (4): 319-26.
41. Fountos G, Tzaphlidou M, Kounadi E, Glaros D., In vivo measurement of radius calcium/phosphorus ratio by X-ray absorptiometry. Appl Radiat Isot. 1999 Sep; 51 (3): 273-8.
42. Dobnig H, Turner RT., Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. Endocrinology. 1995 Aug; 136 (8): 3632-8.
43. Wang Z, Goh J, Das De S, et al., Efficacy of bone marrow-derived stem cells in strengthening osteoporotic bone in a rabbit model. Tissue Eng. 2006 Jul; 12 (7): 1753-61.
44. McCalden RW, McGeough JA, Barker MB, Court-Brown CM., Age-related changes in the tensile properties of cortical bone. The relative importance of changes in porosity, mineralization, and microstructure. J Bone Joint Surg Am. 1993 Aug; 75 (8): 1193-205.
45. Farlay D, Panczer G, Rey C, Delmas PD, Boivin G., Mineral maturity and crystallinity index are distinct characteristics of bone mineral. J Bone Miner Metab. 2010 Jul; 28 (4): 433-45.
46. Ruffoni D, Fratzl P, Roschger P, Klaushofer K, Weinkamer R., The bone mineralization density distribution as a fingerprint of the mineralization process. Bone. 2007 May; 40 (5): 1308-19.
47. Laurent-Matha V, Farnoud MR, Lucas A, Rougeot C, Garcia M, Rochefort H., Endocytosis of pro-cathepsin D into breast cancer cells is mostly independent of mannose-6-phosphate receptors. J Cell Sci. 1998 Sep;111(Pt 1): 2539-49.
48. Gregory AD, Hale P, Perlmutter DH, Houghton AM., Clathrin pit-mediated endocytosis of neutrophil elastase and cathepsin G by cancer cells. J Biol Chem. 2012 Oct; 287 (42): 35341-50.
49. Chan GK, Duque G., Age-related bone loss: old bone, new facts. Gerontology. Jan; 48 (2): 62-71.
50. Castañeda S, Calvo E, Largo R, et al., Characterization of a new experimental model of osteoporosis in rabbits. J Bone Miner Metab. 2008 Jan; 26 (1): 53-9.
51. Lotinun S, Kiviranta R, Matsubara T, et al., Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation. J Clin Invest. 2013 Mar;123(2): 666-81.
52. Tzaphlidou M., Bone architecture: collagen structure and calcium/phosphorus maps. J Biol Phys. 2008 Apr;34(1-2): 39-49.
53. Szulc P, Seeman E, Duboeuf F, Sornay-Rendu E, Delmas PD., Bone fragility: failure of periosteal apposition to compensate for increased endocortical resorption in postmenopausal women. J Bone Miner Res. 2006 Dec;21(12): 1856-63.
54. Masarachia PJ, Pennypacker BL, Pickarski M, et al., Odanacatib reduces bone turnover and increases bone mass in the lumbar spine of skeletally mature ovariectomized rhesus monkeys. J Bone Miner Res. 2012 Mar;27(3): 509-23.
55. Parfitt AM, Villanueva AR, Foldes J, Rao DS., Relations between histologic indices of bone formation: implications for the pathogenesis of spinal osteoporosis. J Bone Miner Res. 1995 Mar; 10 (3): 466-73.
56. Freeman JJ, Wopenka B, Silva MJ, Pasteris JD., Raman spectroscopic detection of changes in bioapatite in mouse femora as a function of age and in vitro fluoride treatment. Calcif Tissue Int. 2001 Mar;68(3): 156-62.
57. Elmore SM, Cantrell WC., Maffucci's syndrome. Case report with a normal karyotype. J Bone Joint Surg Am. 1966 Dec; 48 (8): 1607-13.
58. McClung M, Langdahl B, Papapoulos S, Saag K, et al., Odanacatib anti-fracture efficacy and safety in postmenopausal women with osteoporosis. Results from the Phase III Long-Term Odanacatib Fracture Trial (LOFT). Presented at: ASBMR 2014 Annual Meeting; September 12-15, 2014; Houston, TX. Abstract 1147.